Drugmaker Valeant CEO leaving as investor Ackman joins board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. NVDA
3. META
4. AAPL
5. JNJ
6. AMAT
7. SPY
8. NRIX
9. ASML
10. OIG

Go back to Drugmaker Valeant CEO leaving as investor Ackman joins board

Valeant (VRX) is Not Investable - Piper Jaffray

March 21, 2016 11:34 AM EDT

Piper Jaffray analyst David Amsellem weighed in on Valeant Pharmaceuticals (NYSE: VRX) after the company announced this morning that CEO Michael Pearson will be stepping down, and that William Ackman will be joining the Board of Directors. More importantly, the company cited the... More

Valeant Pharma (VRX) Gives Up Gains; Trades Flat

March 21, 2016 9:43 AM EDT

Valeant Pharma (NYSE: VRX) gives back early gains, now flat

... More